Geode Capital Management, LLC Scynexis Inc Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Scynexis Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 419,448 shares of SCYX stock, worth $247,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
419,448
Previous 418,465 0.23%
Holding current value
$247,474
Previous $280,000 24.29%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$0.68 - $1.19 $668 - $1,169
983 Added 0.23%
419,448 $348,000
Q2 2025

Aug 08, 2025
SELL
$0.67 - $1.07 $685 - $1,094
-1,023 Reduced 0.24%
418,465 $280,000
Q1 2025

May 13, 2025
BUY
$0.9 - $1.41 $12,981 - $20,337
14,424 Added 3.56%
419,488 $398,000
Q4 2024

Feb 12, 2025
BUY
$1.0 - $1.53 $6,208 - $9,498
6,208 Added 1.56%
405,064 $465,000
Q3 2024

Nov 12, 2024
BUY
$1.27 - $2.23 $46,234 - $81,183
36,405 Added 10.04%
398,856 $594,000
Q2 2024

Aug 09, 2024
BUY
$1.4 - $2.77 $10,137 - $20,057
7,241 Added 2.04%
362,451 $724,000
Q1 2024

May 13, 2024
SELL
$1.39 - $2.21 $977 - $1,553
-703 Reduced 0.2%
355,210 $522,000
Q4 2023

Feb 13, 2024
BUY
$1.56 - $2.24 $26,474 - $38,015
16,971 Added 5.01%
355,913 $793,000
Q3 2023

Nov 13, 2023
BUY
$1.93 - $3.64 $51,700 - $97,508
26,788 Added 8.58%
338,942 $772,000
Q2 2023

Aug 11, 2023
BUY
$2.38 - $3.67 $109,779 - $169,282
46,126 Added 17.34%
312,154 $920,000
Q4 2022

Feb 13, 2023
SELL
$1.46 - $2.94 $24,476 - $49,289
-16,765 Reduced 5.93%
266,028 $415,000
Q3 2022

Nov 14, 2022
BUY
$1.83 - $2.93 $91,624 - $146,699
50,068 Added 21.51%
282,793 $678,000
Q2 2022

Aug 12, 2022
BUY
$1.77 - $3.87 $37,231 - $81,405
21,035 Added 9.94%
232,725 $432,000
Q1 2022

May 13, 2022
BUY
$3.56 - $6.66 $137,939 - $258,055
38,747 Added 22.4%
211,690 $827,000
Q4 2021

Feb 11, 2022
BUY
$4.94 - $7.69 $66,793 - $103,976
13,521 Added 8.48%
172,943 $1.05 Million
Q3 2021

Nov 12, 2021
SELL
$5.3 - $7.89 $25,090 - $37,351
-4,734 Reduced 2.88%
159,422 $844,000
Q2 2021

Aug 13, 2021
BUY
$6.5 - $9.97 $186,251 - $285,680
28,654 Added 21.15%
164,156 $1.21 Million
Q1 2021

May 12, 2021
BUY
$6.93 - $9.63 $428,086 - $594,873
61,773 Added 83.78%
135,502 $1.08 Million
Q4 2020

Feb 12, 2021
BUY
$4.28 - $7.87 $25,919 - $47,660
6,056 Added 8.95%
73,729 $564,000
Q3 2020

Nov 13, 2020
BUY
$4.37 - $7.48 $295,731 - $506,194
67,673 New
67,673 $298,000

Others Institutions Holding SCYX

# of Institutions
47
Shares Held
12.5M
Call Options Held
0
Put Options Held
0
View Full List

About SCYNEXIS INC

SCYX Quotes by TradingView
  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $19.3M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email